iShares U.S. Digital Infrastructure and Real Estate ETF (ARCA: IDGT)

最新ニュース iShares U.S. Digital Infrastructure and Real Estate ETF (ARCA:IDGT)

Technology

Real Estate

The Fund seeks to track the investment results of the S&P Data Center, Tower REIT and Communications Equipment Index (the Underlying Index), which measures the performance of stocks of U.S.-listed companies, as well as U.S.-listed American Depository Receipts (ADRs) of foreign companies from developed markets, involved in the ownership and management of data centers, telecommunication towers, and related equipment, as determined by S&P Dow Jones Indices LLC (the Index Provider or SPDJI).

American Tower Corp

Crown Castle International Corp

Equinix, Inc.

Digital Realty Trust Inc.

Uniti Group Inc Com

Fastly Inc

Telefonaktiebolaget LM Ericsson B ADR

Arista Networks Inc.

Cisco Systems, Inc.

Motorola Solutions Inc.

Ciena Corp

Qualcomm Inc.

Marvell Technology Group Ltd.

Nokia Corporation (ADR)

Sba Communications Corp.

Juniper Networks Inc.

iShares US Digital Infrastructure and Real Estate ETF

iShares U.S. Digital Infrastructure and Real Estate ETF

Shares of Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) are soaring Tuesday morning after the satellite imaging company announced a series of major recent contract wins with global defense and intelligence agencies.
What To Know: The <a href="https://www.benzinga.com/pressreleases/25/07/b46193767/planet-secures-four-major-wins-for-ai-enabled-solutions-in-the-defense-and-intelligence-sector">agreements</a> include a €240 million contract funded by Germany, which incorporates a multi-year, eight-figure annual renewal for data and AI services.
In the U.S., the Defense Innovation Unit expanded its contract with Planet to provide AI-driven alerts for the Indo-Pacific Command. The company also <a href="https://www.benzinga.com/pressreleases/25/07/b46193767/planet-secures-four-major-wins-for-ai-enabled-solutions-in-the-defense-and-intelligence-sector">secured</a> a seven-figure expansion with the U.S. Navy for Pacific maritime surveillance and a separate seven-figure deal with NATO for persistent monitoring.
These wins follow Planet&#8217;s recent earnings call where leadership <a href="https://www.benzinga.com/pressreleases/25/06/b45780259/planet-reports-financial-results-for-first-quarter-of-fiscal-year-2026">highlighted</a> a strategic shift toward AI-enabled products. CEO Will Marshall noted that the &#8220;changing geopolitical landscape&#8221; is driving unprecedented interest. Analyst Ratings: In recent <a href="https://www.benzinga.com/quote/PL/analyst-ratings">analyst updates</a>, sentiment on Planet Labs has been mixed. On June 30, Goldman Sachs shifted its stance, downgrading the stock from Buy to Neutral and setting a price target of $4.60. This move suggests a more cautious outlook on the company&#8217;s near-term performance. 
In contrast, on June 24, Cantor Fitzgerald maintained its Overweight rating, viewing the stock favorably with a price target range of $6.30 to $8.50. Earlier in the month, on June 6, both Citigroup and Wedbush reiterated their positive outlooks, maintaining Buy and Outperform ratings, respectively, with price targets in the $5 to $7 range.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, PL shares are trading higher by 4.58% to $6.38 Tuesday morning. The stock has a 52-week high of $7.72 and a 52-week low of $1.73.
Read Also: <a href="https://www.benzinga.com/pressreleases/25/06/b45780259/planet-reports-financial-results-for-first-quarter-of-fiscal-year-2026">Planet Reports Financial Results for First Quarter of Fiscal Year 2026</a>
<h2 class="wp-block-heading">How To Buy PL Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Planet Labs&#8217; case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

News

Planet Labs (PL) Stock Surges On Major Defense Contracts

FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) has outperformed the market over the past 10 years by 10.27% on an annualized basis producing an average annual return of 21.73%. Currently, FTAI Aviation has a market capitalization of $11.35 billion. 
Buying $100 In FTAI: If an investor had bought $100 of FTAI stock 10 years ago, it would be worth $705.38 today based on a price of $110.71 for FTAI at the time of writing.
<h3>FTAI Aviation's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751383856_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

FTAI

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

- Funding agreement contemplates a conversion formula with a potential 30% premium upon conversion and positions the Company for growth, and accelerated advancement of its clinical pipeline programs, CYB003 and CYB004 -
Cybin Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYBN#NYSE">CYBN</a>) (Cboe Canada: CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce the Company has entered into a securities purchase agreement (the "Securities Purchase Agreement") with High Trail Special Situations LLC ("High Trail"), pursuant to which the Company agreed to sell and issue to High Trail up to US$500,000,000 in aggregate principal amount of unsecured convertible debentures (the "Convertible Debentures"). The sale and issue of US$50,000,000principal amount of Convertible Debentures was completed on June 30, 2025 (the "Private Placement"). The sale and issue of US$450,000,000 of the principal amount of Convertible Debentures will be determined at a future date, upon mutual agreement of the parties.

Financing

CYBN

Cybin Raises $50M In Convertible Debenture Private Placement With Potential $500M Total Funding With High Trail Special Situations

Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX CEO Elon Musk has reiterated threats to form a new &#8220;America Party,&#8221; as his public feud with President Donald Trump over the &#8220;<a href="https://www.benzinga.com/markets/economic-data/25/06/46165307/us-credit-rating-would-fall-if-trumps-big-beautiful-bill-is-approved-says-thomas-massie-heres-what-it-means-for-americans">Big Beautiful Bill</a>&#8221; continues to gather steam.
What Happened: The calls for a new U.S. political party gained momentum on July 1 after Musk sharply criticized President Trump's proposed bull, a federal spending package Musk labeled a "disgusting abomination" due to its tax breaks and cuts to essential programs like healthcare and food assistance.
In a viral <a href="https://x.com/elonmusk/status/1939806847504105683">post</a> on X, Musk declared: "If this insane spending bill passes, the America Party will be formed the next day." 
Crypto influencer The Bitcoin Therapist quipped in response, "Time to buy more Bitcoin. He who gets the most BTC wins."
The backlash was swift and widespread. Musk&#8217;s remarks fueled speculation, and within hours, Polymarket <a href="https://polymarket.com/event/will-elon-musk-create-a-new-political-party-by?tid=1751371533284">odds</a> of him launching a political party by December 31, 2025 jumped from 11% to 44%.
Earlier in the day, odds of forming a party within one day of the bill's passage had touched 50%, though later <a href="https://polymarket.com/event/elon-forms-a-new-party-within-1-day-of-the-spending-bill-passing?tid=1751371583078">settled</a> at 21%.
Building Momentum
Musk has increasingly positioned himself as politically independent. 
In a June 5 <a href="https://x.com/elonmusk/status/1930685402631053403">poll</a> on X, he asked: "Is it time to create a new political party in America that actually represents the 80% in the middle?"
The result: 80% voted yes. Musk replied, "The people have spoken. A new political party is needed."
While the billionaire has not taken formal steps toward party formation, his frustration with both major parties, particularly the GOP, has intensified. 
Once Trump's largest individual donor in 2024, contributing over $275 million, Musk's relationship with the former president fractured after he <a href="https://www.benzinga.com/25/05/45661836/tesla-stock-gains-215-after-hours-as-elon-musk-ends-doge-government-role">resigned from his co-chair role</a> in the Department of Government Efficiency (D.O.G.E.) in May 2025, citing clashes over economic policy.
Also Read: <a href="https://www.benzinga.com/markets/equities/25/07/46187311/trump-says-elon-musk-would-close-up-shop-and-head-back-home-to-south-africa-without-subsidies-no-more-rocket-launches-satellites-or-electric-car">Trump Says Elon Musk Would &#8216;Close Up Shop And Head Back Home To South Africa&#8217; Without Subsidies: &#8216;No More Rocket Launches, Satellites, Or Electric Car&#8217;</a>
Why It Matters:  Despite his immense wealth and platform control, especially his ownership of X, analysts warn that creating a successful third party remains an uphill battle. 
The U.S. electoral system strongly favors the two-party structure through ballot access restrictions and first-past-the-post voting mechanics.
History offers a cautionary tale: even Ross Perot's 1992 campaign, backed by substantial funding and national media attention, failed to establish a lasting third-party presence despite capturing 19% of the vote.
Musk, however, offers a unique mix of capital, cultural influence, and a massive online following. 
Whether that can translate into electoral viability remains uncertain—but his growing political ambitions are drawing increasing attention.
What's Next: President Trump responded to Musk&#8217;s threats on Tuesday morning by announcing that &#8216;DOGE&#8217; may &#8220;look into&#8221; the billionaire&#8217;s businesses. TSLA is down over 5% on the day at the time of writing. 
The fate of Trump's spending bill remains in limbo, with the Senate still debating its provisions.
If it fails, Musk's urgency may cool. But his dissatisfaction with both Democrats and Republicans, and clear desire to rally America's political "middle", suggests this won't be the last time we hear calls for the "America Party."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46186733/elon-musk-staging-a-political-comeback-tesla-ceo-sparks-america-party-buzz-as-he-slams-trumps-insane-spending-bill">Elon Musk Staging A Political Comeback? Tesla CEO Sparks &#8216;America Party&#8217; Buzz As He Slams Trump&#8217;s &#8216;Insane Spending Bill&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

TSLA

Elon Musk Slams Donald Trump's 'Insane Spending Bill' As Polymarket Odds Of  'America Party' Launch Surge

NMPAU

Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDCX#NASDAQ">MDCX</a>) with a Buy and maintains $27 price target.

Price Target

Analyst Ratings

MDCX

D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

WIIM

HOOD

HOOD stock has given up its prior gain. Robinhood Markets shares were trading higher after Keybanc raised its price target on the stock from $60 to $110.

Goldman Sachs analysts are cautiously optimistic about the prospect of major U.S. banks returning more capital to shareholders <a href="https://www.benzinga.com/topic/dividend-stocks">through buybacks and dividends</a>. 
Thanks to regulatory changes and strong results in the Federal Reserve's latest stress tests (CCAR), the top five banks are sitting on an estimated $90 billion in excess capital.
The firm believes banks will gradually raise dividends and continue buybacks, especially as new Fed rules free up an estimated $5.5 trillion in balance sheet capacity. This gives banks more flexibility, especially in stressful times.
Among individual banks, Goldman Sachs names Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) and Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) as the "best-positioned stocks."  
<ul class="wp-block-list">
<li>Bank of America stands out for its strong interest income growth (projected 7% annually through 2026), cost discipline, and potential benefit from regulatory reform. Goldman sees upside to both earnings and capital returns, making the stock attractive at current valuations. The analyst rated the stock as Buy, with the price target lifted from $52 to $56.</li>
<li>Wells Fargo, with its regulatory asset cap lifted, is expected to boost growth in core banking and trading businesses. Cost-cutting efforts and efficiency improvements could lift profits significantly, with up to 19% earnings upside forecast. The stock is also rated Buy, with the price target raised from $86 to $92.</li>
</ul>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/595e3a7c988ca80001dc7d9c/richard-ramsden">Analyst Richard Ramsden</a> also revised estimates ahead of the second-quarter results of five other U.S. banks:
<ul class="wp-block-list">
<li>Citigroup Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) &#8211; rated Buy, with price target raised from $85 to $96.</li>
<li>JPMorgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) &#8211; rated Buy, with price target raised from $305 to $323.</li>
<li>US Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) &#8211; rated Neutral, with price target raised from $46 to $49.</li>
<li>PNC Financial Services Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) &#8211; rated Neutral, with price target raised from $178 to $196.</li>
<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) &#8211; rated Neutral, with price target raised from $136 to $147.</li>
</ul>
Ramsden expects banks to report sequential NII (net interest income) growth in the second quarter, due to an uptick in loan growth. The trading revenue environment "remains healthy" in the near term, he added.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46158087/big-banks-pass-feds-2025-stress-test-with-ease-but-some-say-it-was-too-easy">Big Banks Pass Fed&#8217;s 2025 Stress Test With Ease—But Some Say It Was Too Easy</a></li>
</ul>
Image: Shutterstock

Analyst Color

Federal Reserve

$90 Billion Capital Cushion Points To Serious Bank Shareholder Payday: Goldman Sachs

When Grant from Houston called into "<a href="https://www.youtube.com/watch?v=jrjjwWIHIHk">The Ramsey Show</a>," he wasn't looking to stir up family drama. But the story he shared had all the makings of a long-brewing family crisis — one that financial expert Dave Ramsey and John Delony weren't about to sugarcoat.
For decades, Grant's older brother — now 59 — has leaned on their parents for financial support. Loans, bailouts, bad decisions. And now, with their parents in their 80s, things have escalated again.
"They have just recently made me and my brother power of attorney," Grant said.
Ramsey didn't hesitate: "Well, that's useless."
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
<h2 class="wp-block-heading">Twenty Years of Enabling</h2>
It wasn't just a one-time loan or an occasional favor. As Grant explained, his brother has a long track record of asking for help — and getting it. Two loans on his own house. And now, he&#8217;s persuaded their elderly father to take out a home equity loan on their house.
<a href="https://www.benzinga.com/personal-finance/financial-advisors/25/06/46157845/dave-ramsey-caller-is-trying-to-beat-1-8-million-in-debt-with-no-chips-or-haircuts-my-doctor-says-i-need-a-healthy-work-life-balance">Ramsey</a> told Grant his parents didn't have the money to do this if they were taking out loans. "They do," Grant said, "But my dad did not want to sell appreciated stocks in an investment account. So he thought it was easier to take out some equity as opposed to realize a capital gain."
That didn't sit right with Ramsey and Delony.
"Any guy that asks his 80-year-old father to put his house on the block because he's two HELOCs under his own house is just a person who's a mooch," Delony said. He recommended Grant have a serious conversation with his parents about the situation to let them know how he's feeling about all this, even if the conversation doesn't go how Grant would like.
Trending: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a>
<h2 class="wp-block-heading">A Role With No Power</h2>
When Grant mentioned the <a href="https://www.benzinga.com/personal-finance/25/05/45458742/who-can-be-my-financial-power-of-attorney-if-i-dont-have-anyone-suze-orman-advises-listener-who-doesnt-have-family-or-children">power of attorney</a> arrangement, Ramsey was blunt. "I probably tell him, ‘If he&#8217;s on it. I&#8217;m not,'" he said. "This is setting up World War III."
The problem, according to both hosts, is that the parents are trying to avoid conflict by treating both sons equally on paper — even when one clearly has a history of <a href="https://www.benzinga.com/personal-finance/25/03/44389026/youre-scared-and-you-should-be-dave-ramsey-tells-29-year-old-with-nearly-1-million-of-debt-hes-going-to-destroy-her-life-as-she-knows-it">poor financial choices</a>. And while that might seem fair, it's actually a recipe for long-term chaos, especially after the parents pass away.
"They&#8217;re wanting you to tell him no because they&#8217;ve never had the backbone to," Ramsey said. "Your dad's a wimp."
<h2 class="wp-block-heading">What Grant Should Do Next</h2>
Rather than confronting his brother, Ramsey urged Grant to take a different path.
"Go talk to your dad," he said. "Say, ‘Listen, I'm not okay with this guy mooching off y'all…And I don't want to be power of attorney with him.'"
See Also: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
Delony added that Grant doesn't have to be part of the dysfunction to be helpful. He said to tell them, "‘I want to take care of you in your old age. But I can't manage you…and my older brother, who still can&#8217;t be on his own two feet."
<h2 class="wp-block-heading">The Bigger Picture</h2>
Grant's call resonated because it touched on something so many people face: <a href="https://www.benzinga.com/personal-finance/25/01/43217370/i-dont-think-im-ever-going-to-retire-how-gen-x-is-getting-squeezed-between-kids-aging-parents-and-600-billion-in-unpaid-care">aging parents</a>, unequal siblings, and the fallout when tough conversations are postponed for too long.
The message from Ramsey and Delony was clear — clarity now can prevent crisis later. And in families, silence can be far more expensive than speaking up.
Read Next: <a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
Image: Shutterstock

Personal Finance

59-Year-Old Brother 'Mooches' Off Parents For Years And They Just Made Him Power Of Attorney — Dave Ramsey Says 'Your Dad's A Wimp'

Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) has outperformed the market over the past 15 years by 2.97% on an annualized basis producing an average annual return of 15.42%. Currently, Thermo Fisher Scientific has a market capitalization of $157.61 billion. 
Buying $1000 In TMO: If an investor had bought $1000 of TMO stock 15 years ago, it would be worth $8,531.04 today based on a price of $417.76 for TMO at the time of writing.
<h3>Thermo Fisher Scientific's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751382922_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) has outperformed the market over the past 5 years by 4.19% on an annualized basis producing an average annual return of 18.42%. Currently, Alphabet has a market capitalization of $2.12 trillion. 
Buying $100 In GOOGL: If an investor had bought $100 of GOOGL stock 5 years ago, it would be worth $232.84 today based on a price of $174.58 for GOOGL at the time of writing.
<h3>Alphabet's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751382796_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GOOGL

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Morgan Stanley analyst Craig Hettenbach initiates coverage on Omada Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMDA#NASDAQ">OMDA</a>) with a Overweight rating and announces Price Target of $25.

Initiation

OMDA

Morgan Stanley Initiates Coverage On Omada Health with Overweight Rating, Announces Price Target of $25

Morgan Stanley analyst Daniela Haigian assumes CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) with a Overweight rating and announces Price Target of $80.

Morgan Stanley Assumes CarMax at Overweight, Announces Price Target of $80

In January 2025, the U.S. dollar was charging toward its 2022 highs, riding a wave of investor optimism as Donald Trump returned to the White House. Wall Street was betting on tariffs and domestic tax cuts to<a href="https://www.benzinga.com/markets/economic-data/25/06/46146713/trump-dollar-outlook-tariffs-debt"> strengthen the greenback.</a>
However, just six months later, the narrative turned on its head.
The dollar has posted its worst first-half performance since 1991, with the U.S. Dollar Index—a widely followed gauge of dollar strength on Wall Street—down more than 10% year-to-date, hitting levels not seen since September 2021.
Now, the dollar's sharp decline is no longer just a trader's concern. 
It's starting to bite American tourists, who are discovering that their dream vacations abroad—from croissants in Paris to cocktails in Cancun—come with a noticeably higher price tag.
Here are five favorite destinations where U.S. travelers are feeling the squeeze this summer.
<h2 class="wp-block-heading">Paris: That Croissant Just Got A Lot Fancier</h2>
The euro – as tracked by the Invesco CurrencyShares Euro Currency Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXE#NYSE">FXE</a>) – has gained 14% against the dollar this year, sending the exchange rate above 1.18 euros per dollar. 
That means American travelers are now getting less than 0.83 euros per dollar at current exchange rates, as the dollar extended its losing streak to 10 consecutive sessions on July 1—a run not seen since 2003.
Whether it&#8217;s a rooftop view of the Eiffel Tower or a walk along the Seine, your dreamy Parisian holiday is now pricier. 
In May 2024, the average daily rate (ADR) in Paris was $193 when converted into dollars, according to ArRoi, a platform that tracks Airbnb Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) prices.
By May 2025, that figure climbed to $207. If July follows last year's seasonal spike when ADR hit a peak of $220, prices this month could push above $235, assuming similar trends.
<h2 class="wp-block-heading">London: More Pounds, Fewer Dollars</h2>
The British pound – as tracked by the Invesco CurrencyShares British Pound Sterling Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXB#NYSE">FXB</a>) – has gained 9% against the dollar in 2025, with one dollar now buying just 0.72 pounds.
London's ADRs on Airbnb jumped from $154 in May 2024 to $216 this year—a staggering 40% increase. 
With July 2024's ADR at $176, this summer could see London rentals reach $245, based on similar growth.
So if you're eyeing fish and chips by the Thames or a Harry Potter studio tour, prepare to pay London prices in full.
Read also: <a href="https://www.benzinga.com/news/25/06/46171994/emerging-markets-stocks-dollar-outlook">A Weaker Dollar Just Unlocked A Surprise 2025 Winner — And Smart Money Is Moving In</a>
<h2 class="wp-block-heading">Rio de Janeiro: Samba With A Stronger Real</h2>
The Brazilian real has appreciated by 13% against the dollar so far in 2025, making travel to Rio de Janeiro more expensive, even during the off-season.
Rio's average nightly Airbnb cost climbed to $75 in May 2025, up from $64 a year earlier. Food, transportation and tourist attractions are also eating into budgets as the dollar's value shrinks.
Brazil's natural beauty remains breathtaking, but your beachside caipirinha is now served with a stronger exchange rate.
<h2 class="wp-block-heading">Cancun: Peso Packs A Punch</h2>
Even neighboring Mexico is less of a budget-friendly haven this year. While Cancun's cost per night has held steady at around $72, the Mexican peso's gains are making everything else—from margaritas to excursions—more expensive.
You're now getting just 18.70 pesos per dollar, a sharp 9% drop from the 20.70 pesos you would've received at the start of the year.
According to Numbeo, a typical restaurant dinner for two in Cancun now costs 1,000 pesos, or more than $50—and that's before you even order the margaritas.
Toss in tips, taxis and tourist excursions, and your wallet starts feeling the peso's punch.
<h2 class="wp-block-heading">Bangkok: Still Budget—But No Longer A Steal</h2>
If Bangkok is on your list for a bachelor party or epic friends' getaway, get ready to spend a bit more this year.
Thailand remains a budget destination, but inflation and currency changes are closing that gap. 
The Thai baht has strengthened 7% in 2025, while Bangkok's average nightly Airbnb rate has surged from $39 in May 2024 to $51 this year.
If July follows last year's trend—when ADR hit $42—travelers could now be facing nightly rates near $60, a price they didn't even see during peak season in January.
Still cheaper than Western Europe, but not the bargain it once was.
<h2 class="wp-block-heading">The Bottom Line</h2>
What started as a dollar resurgence in early 2025 has turned into a historic slump, leaving U.S. tourists footing higher bills across nearly every major destination abroad. 
With the U.S. Dollar Index down over 10%—its worst start to a year since 1991—the greenback's weakness is hitting travelers where it hurts: their vacation budgets.
That dream summer trip abroad now comes with a steeper price tag, and the dollar simply doesn't go as far as it did just a year ago. 
Read now: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/forex/25/06/46175116/weaker-dollar-stocks-beneficiaries-foreign-revenue">Dollar&#8217;s Biggest Crash In Decades: These 7 Stocks Could Win Big</a></li>
</ul>
Photo: Shutterstock

Currency ETFs

Forex

Travel

Econ #s

Economics

ETFs

ABNB

CurrencyShares British Pound Sterling Trust

A Sinking Dollar Is Making Your Dream Vacation Way More Pricey This Year

<a href="https://about.fb.com/news/2025/07/centralized-campaigns-ai-support-businesses-whatsapp/" title="https://about.fb.com/news/2025/07/centralized-campaigns-ai-support-businesses-whatsapp/">https://about.fb.com/news/2025/07/centralized-campaigns-ai-support-businesses-whatsapp/</a>

'Meta Introduces Centralized Marketing Campaigns, Expanded AI Support And Calling Options For Businesses Using WhatsApp' - Meta Newsroom

Maxim Group analyst Thomas Forte initiates coverage on Fossil Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSL#NASDAQ">FOSL</a>) with a Buy rating and announces Price Target of $5.

FOSL

Maxim Group Initiates Coverage On Fossil Group with Buy Rating, Announces Price Target of $5

BMNR

BitMine Immersion Technologies Shares Resume Trade

International Game Technology Shares Resume Trade

Maxim Group analyst Thomas Forte initiates coverage on Alliance Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AENT#NASDAQ">AENT</a>) with a Buy rating and announces Price Target of $10.

AENT

Maxim Group Initiates Coverage On Alliance Entertainment with Buy Rating, Announces Price Target of $10

Novo Nordisk A/S&#8217; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) executives allegedly ignored internal warnings that the company was unprepared to launch its <a target="_blank" href="https://www.benzinga.com/topic/weight-loss" rel="noreferrer noopener">obesity drug Wegovy</a>.
As rival Eli Lilly and Co.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Zepbound gains momentum, the Danish pharmaceutical giant is grappling with the fallout of those early decisions.
Wegovy, approved in the U.S. in mid-2021, marked a major advancement in obesity treatment and helped Novo generate $46 billion in net profit since then.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/46139132/spain-accuses-novo-nordisk-of-covert-advertising-for-prescription-weight-loss-drugs" rel="noreferrer noopener">Spain Accuses Novo Nordisk Of Covert Advertising For Prescription Weight-Loss Drugs</a>
But the company has struggled to keep pace with Lilly&#8217;s Zepbound, which has surpassed Wegovy in weekly new prescriptions this year.
Amid concerns over its competitiveness in the weight-loss market, Novo is undergoing a leadership shake-up, including <a target="_blank" href="https://www.benzinga.com/news/management/25/05/45466201/ozempic-maker-novo-nordisk-looks-for-new-chief-jorgensen-steps-down" rel="noreferrer noopener">the recent dismissal</a> of CEO Lars Fruergaard Jorgensen and earlier departures like U.S. chief Doug Langa.
Sources told Reuters that during tense internal meetings, sales and marketing staff warned Langa about launching Wegovy too quickly after FDA approval.
They urged a delay until supply and insurance coverage were more secure. With a <a target="_blank" href="https://www.benzinga.com/25/05/45252150/novo-nordisk-expects-fda-decision-for-oral-wegovy-by-end-of-2025-reports-mixed-q1-earnings" rel="noreferrer noopener">list price of up to $1,300 per month</a>, many patients found the drug unaffordable without insurance, and Novo missed an opportunity to build a more stable launch pad while Lilly&#8217;s market entry was still years away.
However, company leadership in Copenhagen held to conservative sales expectations through 2025, Reuters report highlighted, underestimating the scale of demand driven by the global obesity epidemic. Former employees said Novo had internal indicators pointing to stronger uptake but failed to adjust its strategy accordingly.
The consequences were swift. Wegovy&#8217;s launch was plagued by supply shortages, leaving patients without doses and discouraging new users. The high cost also pushed some patients toward the gray market of compounded drugs.
Novo further faced criticism for pricing Wegovy significantly higher than its diabetes drug Ozempic, while Lilly entered the market with Zepbound at $1,080 and provided steep discounts through its LillyDirect pharmacy.
One former insider claimed that Novo hesitated to offer competitive rebates to pharmacy benefit managers (PBMs), limiting the drug&#8217;s accessibility.
This reluctance hurt relationships with insurers and failed to secure broader coverage, placing Novo at a disadvantage compared to Lilly&#8217;s aggressive pricing and reimbursement strategies.
Recently, Novo Nordisk launched its weight-loss drug Wegovy (semaglutide) in India to <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/46076029/novos-india-move-could-reshape-the-weight-loss-drug-war-with-eli-lilly" rel="noreferrer noopener">compete with Eli Lilly</a>.
Price Action: NVO stock is trading higher by 0.13% to 69.11 at last check Tuesday.
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/fda/25/07/46192989/mesoblast-targets-accelerated-fda-approval-for-heart-failure-drug-revascor" target="_blank" rel="noreferrer noopener">Mesoblast Targets Accelerated FDA Approval For Heart Failure Drug Revascor</a></li>
</ul>
Photo by Tobias Arhelger via Shutterstock

Comments

iShares U.S. Digital Infrastructure and Real Estate ETF

ニュース

最新ニュース iShares U.S. Digital Infrastructure and Real Estate ETF (ARCA:IDGT)

ニュース

パートナーシップ

ベンジンガ・グローバル